Standard dosage for one lung cancer treatment may be too high
Wednesday, June 7, 2017 - 10:11
in Health & Medicine
The customary pembrolizumab dose for treatment of metastatic non-small cell lung cancer may be higher than is needed for effective treatment, conclude researchers.